The genes chosen were CEBPB, SGK1, SIGLEC15, MVP, and ITGB2, and the validation was completed in the original REH cell line used for the RNA-Seq analysis, as well as two additional ALL cell lines (SUP-B15 and TOM-1) (Supplementary Fig. S3). This evidence concerns the gene SGK1 and acute lymphoblastic leukemia.